Cellectis
CLLS
57 hedge funds and large institutions have $124M invested in Cellectis in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 23 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
40% more call options, than puts
Call options by funds: $311K | Put options by funds: $222K
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
0.44% less ownership
Funds ownership: 33.84% → 33.4% (-0.44%)
19% less funds holding
Funds holding: 70 → 57 (-13)
36% less capital invested
Capital invested by funds: $194M → $124M (-$70.4M)
57% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$2.88M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$2.48M |
| 3 |
Legal & General Group
London,
United Kingdom
|
+$1.18M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.13M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CII
Capital International Inc
Los Angeles,
California
|
-$10.9M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$8.27M |
| 3 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$1.72M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$1.26M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.17M |
CLLS Hedge Fund Activity: Q4 2021 in Review
57 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2021, worth a combined $124M — down 36% from $194M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CLLS and 10 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 22 added.
The largest buyer was 683 Capital Management, adding an estimated $2.88M. The largest seller was Capital International Inc, exiting entirely with an estimated $10.9M sold.
- 57 institutional investors held Cellectis (CLLS) as of Q4 2021, down from 70 in Q3 2021.
- Funds reported $124M of Cellectis stock for Q4 2021, down 36% quarter-over-quarter.
- 10 funds opened new Cellectis positions in Q4 2021 and 23 closed out, a net change of -13 holders.
- The largest Cellectis buyer in Q4 2021 was 683 Capital Management, an estimated $2.88M added.
- The largest Cellectis seller in Q4 2021 was Capital International Inc, an estimated $10.9M sold.
Based on aggregated 13F filings for Q4 2021.